Edwards Lifesciences (EW) posted astonishing numbers on its new Sapien 3 heart valve and it will soon be the standard for heart doctors worldwide, said TheStreet's Jim Cramer. He said the stock has been on a tremendous run, but it remains a good buy because of the outlook for Sapien 3.
More from Video
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.
There is a lot of Apple news to chew on Wednesday.